IRLAB Therapeutics AB (publ)

IRLAB Therapeutics AB (publ)verified

IRLAB-A.ST

Price:

$1.94

Market Cap:

$164.62M

IRLAB Therapeutics AB (publ) develops drugs for the treatment of Parkinson's disease. The company develops Mesdopetam that is in phase IIb/III clinical studies for the treatment of dyskinesia; and Pirepemat, which is in phase IIb clinical trial for the treatment of Postural dysfunction. Its preclinical stage products include IRL942 and 1009 research programs for the treatment of neurodegenerative disorders and ageing; and IRL757 to treat apathy in neurological diseases. In addition, the company develops P003, a research project that develops drugs for the treatment of newly diagnosed Parkinson's disease. IRLAB Therapeutics AB (publ) was incorporated in 2013 and is based in Gothenburg, Sweden...[Read more]

Industry

Biotechnology

IPO Date

2017-02-28

Stock Exchange

STO

Ticker

IRLAB-A.ST

The ROE as of December 2025 (TTM) for IRLAB Therapeutics AB (publ) (IRLAB-A.ST) is -576.33%

According to IRLAB Therapeutics AB (publ)’s latest financial reports and current stock price. The company's current ROE is -576.33%. This represents a change of 243.83% compared to the average of -167.62% of the last 4 quarters.

IRLAB Therapeutics AB (publ) (IRLAB-A.ST) Historical ROE (quarterly & annually)

How has IRLAB-A.ST ROE performed in the past?

The mean historical ROE of IRLAB Therapeutics AB (publ) over the last ten years is -63.92%. The current -576.33% ROE has changed 801.65% with respect to the historical average. Over the past ten years (40 quarters), IRLAB-A.ST's ROE was at its highest in in the June 2025 quarter at 116.73%. The ROE was at its lowest in in the March 2025 quarter at -733.35%.

Quarterly (TTM)
Annual

Average

-63.92%

Median

-37.77%

Minimum

-254.73%

Maximum

12.96%

IRLAB Therapeutics AB (publ) (IRLAB-A.ST) ROE by Quarter and Year

Discovering the peaks and valleys of IRLAB Therapeutics AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 291.22%

Maximum Annual ROE = 12.96%

Minimum Annual Increase = -402.94%

Minimum Annual ROE = -254.73%

Quarterly (TTM)
Annual
YearROEChange
2024-254.73%65.82%
2023-153.62%291.22%
2022-39.27%-402.94%
202112.96%-149.09%
2020-26.40%-50.16%
2019-52.97%51.90%
2018-34.87%-3.86%
2017-36.27%-11.74%
2016-41.10%218.17%
2015-12.92%-309.21%

IRLAB Therapeutics AB (publ) (IRLAB-A.ST) Average ROE

How has IRLAB-A.ST ROE performed in the past?

The current ROE of IRLAB Therapeutics AB (publ) (IRLAB-A.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-149.21%

5-year avg

-92.21%

10-year avg

-63.92%

IRLAB Therapeutics AB (publ) (IRLAB-A.ST) ROE vs. Peers

How is IRLAB-A.ST’s ROE compared to its peers?

IRLAB Therapeutics AB (publ)’s ROE is less than Lipum AB (publ) (1.71%), greater than Isofol Medical AB (publ) (-69.76%), greater than Bio-Works Technologies AB (publ) (-84.51%), greater than Karolinska Development AB (publ) (-11.56%), greater than Initiator Pharma A/S (-68.70%), greater than Annexin Pharmaceuticals AB (publ) (-112.75%), less than Xbrane Biopharma AB (publ) (28.79%), greater than Alzinova AB (publ) (-21.31%), greater than Active Biotech AB (publ) (-223.35%), greater than Clinical Laserthermia Systems AB (publ) (-57.03%),

Build a custom stock screener for IRLAB Therapeutics AB (publ) (IRLAB-A.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IRLAB Therapeutics AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

IRLAB Therapeutics AB (publ) (IRLAB-A.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like IRLAB Therapeutics AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is IRLAB Therapeutics AB (publ)'s ROE?

How is the ROE calculated for IRLAB Therapeutics AB (publ) (IRLAB-A.ST)?

What is the highest ROE for IRLAB Therapeutics AB (publ) (IRLAB-A.ST)?

What is the 3-year average ROE for IRLAB Therapeutics AB (publ) (IRLAB-A.ST)?

What is the 5-year average ROE for IRLAB Therapeutics AB (publ) (IRLAB-A.ST)?

How does the current ROE for IRLAB Therapeutics AB (publ) (IRLAB-A.ST) compare to its historical average?